Nutrition and Renal Osteodystrophy
スポンサーリンク
概要
- 論文の詳細を見る
1. Nutritional factors, especially calcium, calorie and fat intakes may be important in the treatment with active vitamin D, so that the effect appears more efficient. 2. Incidence of bone changes, due to hyper-parathyroidism in diabetic nephropathy, was less than that in non-diabetic patients under hemodialysis. 3. No effect of control status of diabetes mellitus was demonstrated, regarding incidence of subperiosteal resorption of finger bones. 4. Bone mass was decreased in diabetic patients in whom the control of blood glucose was inadequate.
- 財団法人 学会誌刊行センターの論文
著者
-
Inoue Takashi
Inoue Hospital
-
Nishizawa Yoshiki
Second Department Of Internal Medicine Osaka City University Medical School
-
MORII HIROTOSHI
Second Department of Internal Medicine, Osaka City University
-
MORII HIROTOSHI
Second Department of Internal Medicine Osaka City University
-
NISHIZAWA Yoshiki
Second Department of Internal Medicine, Osaka City University
-
MIKI Takami
Second Department of Internal Medicine, Osaka City Medical School
-
MIKI Takami
Second Department of Internal Medicine, Osaka City University
-
OHNISHI Yasuo
Second Department of Internal Medicine, Osaka City University
-
OKUI Yasuyuki
Second Department of Internal Medicine, Osaka City University
-
SONG Gyeongbu
Second Department of Internal Medicine, Osaka City University
-
YUKIOKA Kazuhiko
Second Department of Internal Medicine, Osaka City University
-
KIKUNAMI Kiichiro
Inoue Hospital
-
MATSUSHITA Yoshiki
Inoue Hospital
関連論文
- -0146- Role of endothelium in hypotensive action of acetylcholine and bradylinin in spontaneously hypertensive rat.(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
- Efficacy and safety of long-term oral falecalcitriol treatment in patients with renal osteodystrophy
- Clinical trial of in-situ hybridization method for the rapid diagnosis of sepsis
- Idiopathic portal hypertension associated with high serum titer of autoantibodies and liver dysfunction
- Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study
- Efficacy of low-dose, intermittent eel calcitonin treatment for osteoporosis
- Synergistic Enhancement by 12-O-Tetradecanoylphorbol-13-acetate and Dibutyryl cAMP of 1α, 25-Dihydroxyvitamin D_3 Actionin Human Promyelocytic Leukemic HL-60 Cells
- QTc INTERVAL PROLONGATION AND CLINICAL PEATURES IN CHRONIC HEMODIALYSIS PATIENTS : Hypertension : 53 Annual Scientific Meeting, Japanese Circulation Society
- A case of B Cell Lymphoma Complicated by Hypercalcemia and Acute Renal Insufficiency
- Efficacy and safety of oral falecalcitriol in reducing parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism
- Insulin Secretion in Patients with Hyperthyroidism: in Relation to Abnormalities in Carbohydrate Metabolism
- Closer Correlation between Serum Triiodothyronine and Basal Metabolic Rate during Antithyroid Drug Treatment in Patients with Graves Disease
- Statement on the diagnosis and management of osteoporosis from the Consensus Development Conference at the Second International Conference on Osteoporosis,Osaka 1997
- A Case Report on Disequilibrium Hypercalcemia in Hyperthyroidism : Comparison of Calcium Metabolism with Other Patients with Hyperthyroidism
- Effect of Corticosteroids in 10 Cases of Methimazole-Induced Agranulocytosis
- Preventive Effect of Salmon Calcitonin on Restraint-Induced Gastric Ulcer in Rats
- Secretion of Gastrin and Calcitonin after Ingestion of Meat Extract in Patients with Peptic Ulcer
- A Case Report of Turner's Sydrome with Ring X Chromosome
- Effects of Uremic Serum on 1, 25-Dihydroxyvitamin D3-Induced Differentiation of a Human Promyelocytic Leukemia Cell Line, HL-60
- Lipoprotein Metabolism in Normolipidemic Obese Women during Very Low Calorie Diet:Changes in High Density Lipoprotein
- Effects of Dietary Phosphorus Restriction on Secondary Hyperparathyroidism in Hemodialysis Patients during Intermittent Oral High-dose 1, 25(OH)2D3 Treatment
- Obesity as a Determinant of Regional Bone Mineral Density
- Bone Mineral Loss in Patients on Maintenance Hemodialysis with Hyperphosphatemia Treated with 1α-Hydroxycholecalciferol and Calcium Carbonate
- Total and Regional Bone Mineral Content in Patients with Non-Insulin Dependent Diabetes Mellitus
- Cardiac Function and Exercise Capacity of Diabetic Patients
- Calcium Metabolism in Diabetes Mellitus
- Nutrition and Renal Osteodystrophy